Our company’s name was inspired by Miach, a mythical Irish healer. Miach Orthopaedics, like this healer, is dedicated to designing technologies intended to facilitate new tissue growth. The company is developing bio-engineered surgical implants for connective tissue repair. Our initial focus is on the Bridge-Enhanced® ACL Repair (BEAR®) technology as a viable alternative to conventional ACL reconstruction for patients who have sustained an anterior cruciate ligament (ACL) injury.
The BEAR technology was pioneered by Martha Murray, M.D., at Boston Children’s Hospital Department of Orthopaedic Surgery before establishing Miach Orthopaedics as a privately held company located in the Boston area.
Martha Shadan joined Miach Orthopaedics as president and chief executive officer in January 2019. During 2018, Shadan served as global vice president of marketing at Smith & Nephew plc, a role she assumed after the company acquired Rotation Medical, where she was president and CEO. Shadan led Rotation Medical through FDA approval and commercialization of the Rotation Medical Bioinductive Implant for rotator cuff tears (now known as REGENETEN), as well as the company's acquisition by Smith & Nephew in December 2017.
Shadan has more than three decades of experience in the life science industry as a business leader in a variety of both large and start-up organizations. Prior to joining Rotation Medical, she was the president of the Trauma Division at Zimmer where she managed the P&L for the global business. Shadan served at Covidien as vice president/general manager of Vascular Therapies and vice president/general manager BioSurgery and Sports Surgery. Other companies that have benefited from Shadan's experience and leadership include Bristol Myers Squibb Co. and Merck Millipore.
Shadan is the chairwoman of the Board of Directors for a medical device start-up, IlluminOss. She is actively involved with the Advanced Medical Technology Association (AdvaMed), serving on the Board of Directors since 2017; being a member of the Accel Board of Directors since 2015 and currently serving as its chairwoman. Accel is the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical technology manufacturers. Shadan chairs the Diversity and Inclusion Committee for AdvaMed and is a founding member of the Leadership Circle for the Women's Executive Network (WEN). She is also a board advisor for several other companies.
Shadan holds a master of business administration from Northeastern University, master of science in biology from Michigan State University, and bachelor of science in biology from the University of New Hampshire.
Martha Murray, M.D., is founder of Miach Orthopaedics. She is also a professor of orthopaedic surgery at Harvard Medical School and a practicing orthopaedic surgeon in the Sports Medicine Division at Boston Children’s Hospital. Dr. Murray has specialized in the care of patients with knee injuries, and she is internationally recognized as an expert in the care of sports injuries of the knee, including ACL, meniscus and osteochondritis dissecans lesions, for the past 15 years.
Dr. Murray pioneered the BEAR implant with initial research funding provided by the NFL Players Association, Boston Children’s Hospital and the National Institutes of Health.
Dr. Murray has over 70 publications in the area of ACL and meniscus surgery. She has won multiple national awards for her work advancing the care of patients with these injuries, including the Kappa Delta and Cabaud Memorial Awards, respectively the highest research awards in orthopedic surgery and sports medicine.
Dr. Murray received her master’s degree in materials science and engineering from Stanford University and her medical degree from the University of Pennsylvania. She completed a residency in orthopedic surgery at Harvard Medical School and fellowships in pediatric orthopedics and sports medicine at Boston Children’s Hospital.
James Ness has consulted for several leading venture-funded medical device companies, including Tendyne, superDimension, EV3, Metavention, Urotronic and Rotation Medical. He earned his master of business administration degree from the Carlson School of Management at the University of Minnesota and bachelor’s degree from Luther College in Decorah, Iowa.
Pieter Wolters has served as managing director at DSM Venturing since 2012 and also serves on the boards of directors of Interface Biologics, Bio2 Technologies, Frontier Nutrition, Leading Edge Chrystal Technologies, and until the recent acquisition by Teleflex, Essential Medical. Before DSM, he was a repeat life science startup entrepreneur, including co-founder and CEO of OrthAlign and IsoTis OrthoBiologics. He earned his master's degree in law from Leiden University, The Netherlands.
Joyce Erony has more than 30 years of experience as a principal in investing activities, business development and investment banking. Prior to founding Majalin in 2015, she was a managing director at Signet Healthcare Partners, a growth capital healthcare fund in New York. Erony has led or co-led investments Inspire Medical Systems (IPO), Essential Medical (sale), Icon Biosystems (sale), Peak Surgical (sale), Dow Parma Sciences (sale), Anteis (sale) and Atlantis (sale). She is currently a director of Inspire Medical Systems and Miach. Based in New York City, Erony leads the firm’s activities in med tech and specialty pharma. Previously, Erony was a strategic advisor to Alcon Labs and a managing director at Citigroup, responsible for the Bank’s activities in specialty pharmaceuticals and medical devices.
Sean Sansiveri directs the NFLPA’s health, safety and medical research initiatives, including implementation of standardized protocols governing the evaluation and management of concussions and a long-term research partnership with Harvard University and Harvard Medical School. He is also is an adjunct professor for Georgetown University, School of Continuing Studies.
Dr. Chad Mathis brings a robust body of knowledge of orthopedic surgery, having practiced orthopedic surgery for over 15 years. He is board certified by the American Board of Orthopaedic Surgery. He earned his master of business administration and medical degrees from Indiana University, and his bachelor’s degree from University of Evansville in Indiana.
Dr. Richard Parker has dedicated his practice to the field of sports medicine, sports-related injuries and arthroscopic knee surgery. He served as head team physician for the NBA’s Cleveland Cavaliers from 2000-2017, is a national and international presenter and has written more than 200 publications. He earned his medical degree from The Ohio State University.